Treatment of contaminated Flowback water in shale gas development

Flowback water from shale gas well drilling has a high TDS (total dissolved solids) content, ranging from 5000 ppm to 261,000 ppm, along with a TSS (total suspended solids) content of 300–3000 mg/L. Recently, the rapid expansion of shale gas production in Marcellus Formation has raised serious environmental concerns about the large amount of flowback water in this area. In this project a process based on ceramic membrane filtration and ion-exchange is optimised for the treatment of the flowback water from Marcellus Formation. Mixed bed ion-exchange will then be employed to reduce the high TDS concentration of flowback water. Finally, a preliminary cost estimation of the proposed treatment process will be conducted. The studied process contains a combination of two MF (microfiltration) membranes. After treatment, all TSS and >99% of TDS should be successfully removed from the flowback water to meet the criteria for surface discharge. The cost estimation of the treatment is expected to be around 18.4 $/m

Criteria of selecting appropriate Delay Analysis Methods (DAM) for mega construction projects

Nowadays, one of the major sources of issues in the construction sector in the Middle East and North Africa (MENA) region is the Extension of time (EOT) claims, which is so hard to resolve. Authors and practitioners have started trials in numerous academic studies to show how to properly deploy Delay Analysis Methods (or "DAMs") and to give practitioners executive guidelines to support them with proper analyses and claim resolution. The awareness of the use of these methods is essential to realize their restrictions and capacity to fit in with various project circumstances and to select appropriate delay analysis methods. The main objective of this research is to provide a guide for the selection of appropriate DAM by defining a list of important criteria that have the most preference in choosing the effective method. These criteria will be rated by collecting feedback from experts in the MENA region through questionnaires. The survey was conducted in the United Arab Emirates (UAE) for the abundance of multinational firms working on mega construction projects with multicultural backgrounds and diversity of expertise in addition to the availability of carrying out interviews when needed and the widespread adoption of standard international construction contracts. Then, the possibility of ranking is calculated by using the Relative Importance Index (RII). This ranking will be considered as an important tool for the proper selection of convenient delay analysis methods. Ultimately this paper will facilitate the selection of appropriate DAM by Delay analyst through investigating project circumstances by mapping it with current ranked criteria

Digital trio: integration of BIM–EIR–IoT for facilities management of mega construction projects

Facility Management (FM) has increasingly focused on integrating Building Information Modeling (BIM) with the Internet of Things (IoT), known as digital twins, in large-scale development projects. Effective BIM integration in FM requires improved cooperation among participants across various project stages. This digital revolution aims to enhance planning, construction, and asset management efficiency, benefiting all parties. However, BIM utilization in FM is limited by incomplete owner understanding, insufficient data accessibility, and stakeholders’ unfamiliarity with BIM procedures and standards. Despite recognizing BIM’s significance, the FM industry faces significant implementation challenges. Facility managers often lack a comprehensive understanding of BIM’s benefits in streamlining operations and enhancing cost efficiency, as well as the necessary skills for its use. Addressing these barriers requires developing an Employer’s Information Requirements (EIR) document at a project’s outset, providing a strategic plan and vision for all involved parties. BIM and IoT are pivotal technologies for transitioning to efficient building operations and crucial for reducing time, costs, and operational challenges throughout any project. This research aims to establish a digital trio workflow, integrating BIM, EIR, and IoT to maximize stakeholder benefits. It explores how preparing the EIR through stakeholder communication can improve design processes, sustainability, efficiency, cost, and time, especially for megaprojects

Developing standard BIM execution plans for complex construction projects

This study addresses the critical need for standardizing building information modeling (BIM) execution plans (BEPs) in the architecture, engineering, construction, and operations (AECO) sector. Through the analysis of 36 BEP documents from international organizations, we have identified crucial components and put forth a comprehensive framework with the objective of improving digital transformation and collaboration in intricate construction projects. This study utilizes scientometric analysis to chart the development of BEP standards and incorporates empirical data from industry surveys to verify the suggested framework. The results of our research emphasize the advantages of using standardized building execution plans (BEPs) to decrease inefficiencies and enhance project outcomes. This makes a substantial contribution to the field of building information modeling (BIM) implementation

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Background: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods: Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0–100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0–100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings: In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8–98·1) in Iceland, followed by 96·6 (94·9–97·9) in Norway and 96·1 (94·5–97·3) in the Netherlands, to values as low as 18·6 (13·1–24·4) in the Central African Republic, 19·0 (14·3–23·7) in Somalia, and 23·4 (20·2–26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1–93·6) in Beijing to 48·0 (43·4–53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6–68·8) in Goa to 34·0 (30·3–38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation: GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view—and subsequent provision—of quality health care for all populations

Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Background Acute meningitis has a high case-fatality rate and survivors can have severe lifelong disability. We aimed to provide a comprehensive assessment of the levels and trends of global meningitis burden that could help to guide introduction, continuation, and ongoing development of vaccines and treatment programmes.AA received funding from Department of Science and Technology, Government of India, New Delhi, through INSPIRE Faculty Award Scheme. HB was financially supported by Mazandaran University of Medical Sciences, Sari, Iran. AB received support for research from the Project of Ministry of Education, Science and Technology of the Republic of Serbia (No. III45005). TWB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the Federal Ministry of Education and Research. FC reports European Union (FEDER funds POCI/01/0145/FEDER/007728 and POCI/01/0145/ FEDER/007265) and National Funds (FCT/MEC, Fundação para a Ciência e a Tecnologia and Ministério da Educação e Ciência) under the Partnership Agreements PT2020 UID/MULTI/04378/2013 and PT2020 UID/QUI/50006/2013. HF was financially supported by Urmia University of Medical sciences, Urmia, Iran. EF reports European Union (FEDER funds POCI/01/0145/FEDER/007728 and POCI/01/0145/FEDER/007265) and National Funds (FCT/MEC, Fundação para a Ciência e a Tecnologia and Ministério da Educação e Ciência) under the Partnership Agreements PT2020 UID/MULTI/04378/2013 and PT2020 UID/QUI/50006/2013. JK has received research funding from Merck Pharmaceuticals. AM acknowledges that Imperial College London is grateful for support from the NW London National Institute of Health and Research Collaboration for Leadership in Applied Health Research and Care. UOM acknowledges funding from the German National Cohort Study Federal Ministry of Education and Research Grant #01ER1511/D. AMS was supported by a fellowship from the Egyptian Fulbright Mission Program. MSM acknowledges the support from the Ministry of Education, Science and Technological Development, Republic of Serbia (Contract No. 175087). KBT acknowledges funding supports from the Maurice Wilkins Centre for Biodiscovery, Cancer Society of New Zealand, Health Research Council, Gut Cancer Foundation, and the University of Auckland. CSW’s work is funded by the South African Medical Research Council and the National Research Foundation of South Africa (Grant Numbers: 106035 and 108571)

Global, regional, and national incidence, prevalence, andyears lived with disability for 354 diseases and injuries for195 countries and territories, 1990–2017: a systematicanalysis for the Global Burden of Disease Study 2017

The Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment of incidence, prevalence, and years lived with disability (YLDs) for 354 causes in 195 countries and territories from 1990 to 2017. Previous GBD studies have shown how the decline of mortality rates from 1990 to 2016 has led to an increase in life expectancy, an ageing global population, and an expansion of the non-fatal burden of disease and injury. These studies have also shown how a substantial portion of the world’s population experiences non-fatal health loss with considerable heterogeneity among different causes, locations, ages, and sexes. Ongoing objectives of the GBD study include increasing the level of estimation detail, improving analytical strategies, and increasing the amount of high-quality data.Research reported in this publication was supported by the Bill & Melinda Gates Foundation, the University of Melbourne, Public Health England, the Norwegian Institute of Public Health, St Jude Children’s Research Hospital, the National Institute on Ageing of the National Institutes of Health (award P30AG047845), and the National Institute of Mental Health of the National Institutes of Health (award R01MH110163)